Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in Japan
Authors:
Open Access
- 28 May 2021
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Oncology
- Vol. 7 (8) , 1141-1148
Abstract
An outbreak of pneumonia of unknown etiology was reported in Wuhan City, Hubei Province, China, in December 2019. It was identified as pneumonia caused by novel coronavirus SARS-CoV-2, and the disease was named COVID-19 by the World Health Organization. COVID-19 has spread globally, and the number of new cases reported is continuously rising. As of February 1, 2021, there have been more than 102 million confirmed cases with 2.22 million deaths worldwide and 389 000 cases with 5722 deaths in Japan.1Keywords
This publication has 33 references indexed in Scilit:
- SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, ChinaJAMA Oncology, 2020
- Italian doctors call for protecting healthcare workers and boosting community surveillance during covid-19 outbreakBMJ, 2020
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in ChinaThe Lancet Oncology, 2020
- Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak — United States, December 31, 2019–February 4, 2020MMWR. Morbidity and Mortality Weekly Report, 2020
- Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse eventsJournal for ImmunoTherapy of Cancer, 2018
- Lymphocyte depletion and repopulation after chemotherapy for primary breast cancerBreast Cancer Research, 2016
- World Medical Association Declaration of HelsinkiJAMA, 2013
- Blocking of PDL-1 Interaction Enhances Primary and Secondary CD8 T Cell Response to Herpes Simplex Virus-1 InfectionPLOS ONE, 2012
- Immunogenicity and safety of the influenza A H1N1v 2009 vaccine in cancer patients treated with cytotoxic chemotherapy and/or targeted therapy: the VACANCE studyAnnals of Oncology, 2011
- Low immunogenicity of seasonal trivalent influenza vaccine among patients receiving docetaxel for a solid tumour: results of a prospective pilot studyBritish Journal of Cancer, 2011